GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 191 filers reported holding GENMAB A/S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,694,486 | -19.4% | 106,291 | -1.7% | 0.03% | -16.1% |
Q4 2022 | $4,582,674 | +16.4% | 108,138 | -11.7% | 0.03% | +10.7% |
Q3 2022 | $3,937,000 | +0.6% | 122,511 | +1.7% | 0.03% | -12.5% |
Q2 2022 | $3,913,000 | -31.3% | 120,424 | -23.5% | 0.03% | -17.9% |
Q1 2022 | $5,694,000 | +3.9% | 157,402 | +13.7% | 0.04% | +11.4% |
Q4 2021 | $5,478,000 | -8.1% | 138,488 | +1.5% | 0.04% | -14.6% |
Q3 2021 | $5,963,000 | +99283.3% | 136,448 | +100229.4% | 0.04% | – |
Q2 2021 | $6,000 | -99.8% | 136 | -99.8% | 0.00% | -100.0% |
Q1 2021 | $2,985,000 | -3.9% | 76,449 | +0.1% | 0.02% | 0.0% |
Q4 2020 | $3,106,000 | -44.8% | 76,382 | -50.3% | 0.02% | -52.8% |
Q3 2020 | $5,622,000 | +13.3% | 153,563 | +4.9% | 0.05% | +1.9% |
Q2 2020 | $4,963,000 | +17.9% | 146,430 | -24.1% | 0.05% | +10.6% |
Q1 2020 | $4,210,000 | -2.1% | 192,862 | +0.1% | 0.05% | +2.2% |
Q4 2019 | $4,301,000 | – | 192,622 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |